<DOC>
	<DOCNO>NCT01795690</DOCNO>
	<brief_summary>The purpose registry record information routine treatment anemia cancer patient Germany . An overview current treatment anemia German outpatient center hospital provide . Primary outcome parameter , e.g . improvement hemoglobin level change QoL , well patient characteristic different treatment analyze .</brief_summary>
	<brief_title>Clinical Tumor Anemia Registry ( TAR )</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<criteria>Histologically confirm malignant disease Hemoglobin level &lt; 11 g/dl ( female ) &lt; 12 g/dl ( male ) Start antianemic therapy 7 day prior informed consent Performance status 0 3 ( KarnofskyIndex &gt; = 40 % ) Minimum age : 18 year Informed write consent Hypersensitivity antianemic therapy Myelodysplastic Syndrome Experimental antianemic therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Cancer</keyword>
	<keyword>Hemoglobin</keyword>
	<keyword>Quality Life</keyword>
	<keyword>FACT-An</keyword>
	<keyword>FACT-GP</keyword>
	<keyword>Erythropoiesis-Stimulating Agents ( ESA )</keyword>
	<keyword>Epoetin</keyword>
	<keyword>Ferric Carboxymaltose</keyword>
	<keyword>Blood Transfusions</keyword>
</DOC>